We are live on ! Find out more
PJP icon

Invesco Pharmaceuticals ETF
PJP

90 hedge funds and large institutions have $113M invested in Invesco Pharmaceuticals ETF in 2017 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 22 increasing their positions, 31 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

6% more capital invested

Capital invested by funds: $107M → $113M (+$6.24M)

1.41% more ownership

Funds ownership: 14.23% → 15.64% (+1.4%)

9% less funds holding

Funds holding: 99 → 90 (-9)

29% less repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 31

54% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 13

Holders
90
Holders Change
-9
Holders Change %
-9.09%
% of All Funds
2.24%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
6
Increased
22
Reduced
31
Closed
13
Calls
$1.65M
Puts
–
Net Calls
+$1.65M
Net Calls Change
+$394K

Top Buyers

Rank Fund Capital Flow
1
TSS
Two Sigma Securities
New York
+$14.3M
2
Creative Planning
Creative Planning
Kansas
+$1.37M
3
VF
Virtu Financial
New York
+$638K
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$390K
5
Jane Street
Jane Street
New York
+$322K

Top Sellers

Rank Fund Capital Flow
1
AI
Atria Investments
North Carolina
-$3M
2
Citadel Advisors
Citadel Advisors
Florida
-$2.38M
3
TRCT
Tower Research Capital (TRC)
New York
-$2.27M
4
Bank of America
Bank of America
North Carolina
-$1.34M
5
UBS Group
UBS Group
Switzerland
-$1.05M
Name Holding Trade Value Shares
Change 		Change in
Stake
TRCT
26
Tower Research Capital (TRC)
New York
$751K -$2.27M -35,990 -76%
IFWM
27
Institute for Wealth Management
Colorado
$748K – – –
BCM
28
BTR Capital Management
California
$747K – – –
Chevy Chase Trust
29
Chevy Chase Trust
Maryland
$719K -$25.3K -400 -4%
VF
30
Virtu Financial
New York
$660K +$638K +10,106 New
FHA
31
Flagship Harbor Advisors
Massachusetts
$580K – – –
Citigroup
32
Citigroup
New York
$539K -$34.8K -551 -6%
FI
33
FormulaFolio Investments
Michigan
$495K +$11.9K +188 +3%
JCM
34
Jacobi Capital Management
Pennsylvania
$444K +$69.2K +1,095 +20%
Brown Advisory
35
Brown Advisory
Maryland
$423K – – –
SPC
36
Sigma Planning Corp
Michigan
$414K +$29.8K +472 +8%
SB
37
Suntrust Banks
Georgia
$409K -$884 -14 -0.2%
CS
38
Credit Suisse
Switzerland
$405K – – –
HighTower Advisors
39
HighTower Advisors
Illinois
$344K -$35.4K -561 -10%
SG Americas Securities
40
SG Americas Securities
New York
$285K – – –
SWM
41
Stockman Wealth Management
Montana
$277K +$253 +4 +0.1%
IA
42
IFP Advisors
Florida
$264K +$17.6K +279 +7%
JP Morgan Chase
43
JP Morgan Chase
New York
$261K +$180K +2,844 +242%
NHC
44
Nicholas Hoffman & Company
Georgia
$248K – – –
CFA
45
Cahill Financial Advisors
Minnesota
$241K -$75.5K -1,195 -25%
JMPWA
46
JP Morgan Private Wealth Advisors
California
$241K – – –
NFC
47
Northeast Financial Consultants
Connecticut
$237K -$357K -5,650 -61%
ED
48
Exane Derivatives
France
$166K +$46.7K +740 +41%
FDCDDQ
49
Federation des caisses Desjardins du Quebec
Quebec, Canada
$159K -$947 -15 -0.6%
SEI Investments
50
SEI Investments
Pennsylvania
$145K – – –
1
2
3 4 5

PJP Hedge Fund Activity: Q3 2017 in Review

90 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Invesco Pharmaceuticals ETF (PJP) for Q3 2017, worth a combined $113M — up 5.8% from $107M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of PJP and 6 opened new positions — a net loss of 7 holders — while 31 trimmed existing stakes and 22 added.

The largest buyer was Two Sigma Securities, opening a new position worth an estimated $14.3M. The largest seller was Atria Investments, exiting entirely with an estimated $3M sold.

  • 90 institutional investors held Invesco Pharmaceuticals ETF (PJP) as of Q3 2017, down from 99 in Q2 2017.
  • Funds reported $113M of Invesco Pharmaceuticals ETF stock for Q3 2017, up 5.8% quarter-over-quarter.
  • 6 funds opened new Invesco Pharmaceuticals ETF positions in Q3 2017 and 13 closed out, a net change of -7 holders.
  • The largest Invesco Pharmaceuticals ETF buyer in Q3 2017 was Two Sigma Securities, an estimated $14.3M added.
  • The largest Invesco Pharmaceuticals ETF seller in Q3 2017 was Atria Investments, an estimated $3M sold.

Based on aggregated 13F filings for Q3 2017.